News

Alta’s stock price has taken a beating over the past six months, shedding 20.9% of its value and falling to $5.10 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their next move.

Over the last six months, Alight’s shares have sunk to $6.25, producing a disappointing 13.9% loss while the S&P 500 was flat. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Peloton has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 38.7% and now trades at $7.17. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Amdocs has been treading water for the past six months, recording a small return of 3.2% while holding steady at $89.48.

What a fantastic six months it’s been for Zevia. Shares of the company have skyrocketed 95.3%, hitting $2.09. This run-up might have investors contemplating their next move.

Over the past six months, IDEX’s shares (currently trading at $184.50) have posted a disappointing 13.2% loss while the S&P 500 was flat. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.